India, May 7 -- While reporting financial results for the first quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings, revenue growth and organic revenue growth guidance for the full-year 2025 to primarily reflect improved net bookings in the DSA segment during the first quarter.
For fiscal 2025, the company now projects earnings in the range of $4.35 to $4.85 per share and adjusted earnings in the range of $9.30 to $9.80 per share on a revenue decline of 5.5 to 3.5 percent, with organic revenue decline of 4.5 to 2.5 percent.
Previously, the company expected earnings in the range of $4.30 to $4.80 per share and adjusted earnings in the range of $9.10 to $9.60 per share on a reven...